Skip to content

Semaglutide clinical trials: 210 trials

Page 5 of 5

  1. Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

    NCT07713992 · Not applicable · Not yet recruiting

    Linked paper with results

  2. Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

    NCT07302802 · Phase not stated · Recruiting

    Linked paper with results

  3. The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes

    NCT05078255 · Not applicable · Completed

    Linked paper with results

  4. Rebalancing the Fat Content of the Heart and Muscles

    NCT07065383 · Not applicable · Recruiting

    Linked paper with results

  5. Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus

    NCT06060392 · Not applicable · Recruiting

    Linked paper with results

  6. GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes

    NCT07858864 · Phase not stated · Recruiting

    Linked paper with results

  7. Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

    NCT06154486 · Phase not stated · Completed

    Linked paper with results

  8. Exercise and GLP-1 RA on Insulin Secretion

    NCT04383197 · Not applicable · Status unknown

    Linked paper with results

  9. Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.

    NCT05419726 · Phase not stated · Recruiting

    Linked paper with results

  10. Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

    NCT06555146 · Not applicable · Status unknown

    Linked paper with results

How PepBank reports evidence